Table 3. Type-specific HPV prevalences with exact binomial 95% confidence intervals (CI) by cytology triage test result.
|
Cytology triage |
||||||||
|---|---|---|---|---|---|---|---|---|
| |
Normal (n=1582) |
ASC-US (n=594) |
LSIL+ (n=398) |
Total (n=2574) |
||||
| Type(s) | n | % (95% CI) | n | % (95% CI) | n | % (95% CI) | n | % (95% CI) |
| HPV 16 |
143 |
9.0 (7.7–10.6) |
58 |
9.8 (7.5–12.4) |
112 |
28.1 (23.8–32.8) |
313 |
12.2 (10.9–13.5) |
| HPV 18 |
64 |
4.0 (3.1–5.1) |
29 |
4.9 (3.3–6.9) |
24 |
6.0 (3.9–8.8) |
117 |
4.5 (3.8–5.4) |
| HPV 31 |
117 |
7.4 (6.2–8.8) |
60 |
10.1 (7.8–12.8) |
53 |
13.3 (10.1–17.1) |
230 |
8.9 (7.9–10.1) |
| HPV 33 |
52 |
3.3 (2.5–4.3) |
23 |
3.9 (2.5–5.8) |
29 |
7.3 (4.9–10.3) |
104 |
4.0 (3.3–4.9) |
| HPV 35 |
24 |
1.5 (1.0–2.2) |
18 |
3.0 (1.8–4.7) |
11 |
2.8 (1.4–4.9) |
53 |
2.1 (1.5–2.7) |
| HPV 39 |
45 |
2.8 (2.1–3.8) |
21 |
3.5 (2.2–5.4) |
19 |
4.8 (2.9–7.4) |
85 |
3.3 (2.6–4.1) |
| HPV 45 |
68 |
4.3 (3.4–5.4) |
30 |
5.1 (3.4–7.1) |
15 |
3.8 (2.1–6.1) |
113 |
4.4 (3.6–5.2) |
| HPV 51 |
51 |
3.2 (2.4–4.2) |
31 |
5.2 (3.6–7.3) |
36 |
9.0 (6.4–12.3) |
118 |
4.6 (3.8–5.5) |
| HPV 52 |
96 |
6.1 (4.9–7.4) |
44 |
7.4 (5.4–9.8) |
21 |
5.3 (3.3–8.0) |
161 |
6.3 (5.4–7.3) |
| HPV 56 |
49 |
3.1 (2.3–4.1) |
31 |
5.2 (3.6–7.3) |
27 |
6.8 (4.5–9.7) |
107 |
4.2 (3.4–5.0) |
| HPV 58 |
66 |
4.1 (3.2–5.2) |
41 |
6.9 (5.0–9.2) |
21 |
5.3 (3.3–8.0) |
128 |
5.0 (4.2–5.9) |
| HPV 59 |
30 |
1.9 (1.3–2.7) |
13 |
2.2 (1.2–3.7) |
7 |
1.8 (0.7–3.6) |
50 |
1.9 (1.4–2.6) |
| HPV 68 |
75 |
4.7 (3.7–5.9) |
25 |
4.2 (2.7–6.2) |
10 |
2.5 (1.2–4.6) |
110 |
4.3 (3.5–5.1) |
| Group 1/2Aa |
777 |
49.1 (46.6–51.6) |
376 |
63.3 (59.3–67.2) |
318 |
79.9 (75.6–83.7) |
1471 |
57.1 (55.2–59.1) |
| Group 2Bb |
153 |
9.7 (8.3–11.2) |
74 |
12.5 (9.9–15.4) |
37 |
9.3 (6.6–12.6) |
264 |
10.3 (9.1–11.5) |
| Group 3c |
53 |
3.4 (2.5–4.4) |
8 |
1.3 (0.6–2.6) |
5 |
1.3 (0.4–2.9) |
66 |
2.6 (2.0–3.3) |
| Any HPV | 983 | 62.1 (59.7–64.5) | 458 | 77.1 (73.5–80.4) | 360 | 90.5 (87.1–93.2) | 1801 | 70.0 (68.2–71.7) |
a
Infection with one or more Group 1/2A HPV type (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68), coinfection with HPV types of Group 2B and/or Group 3 allowed.
b
Infection with one or more Group 2B HPV type (26, 30, 53, 66, 67, 69, 70, 73 and 82), coinfection with HPV types of Group 3 allowed.
c
Infection with one or more Group 3 HPV type (6, 7, 9, 11, 40, 42, 43, 61, 74, 81, 83, 86, 87, 89, 90, 91 and 114).